zoledronic acid has been researched along with Complication, Postoperative in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 11 (73.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, Y; Huang, S; Ke, Y; Liang, C; Liang, G; Xiao, D; Zheng, X; Zhu, X; Zhuang, J | 1 |
Beth-Tasdogan, NH; Hussein, H; Mayer, B; Zolk, O | 1 |
Amling, M; Butscheidt, S; Rolvien, T; Zustin, J | 1 |
Alvarenga, JC; Araújo, MJCLN; Custódio, MR; David-Neto, E; Dos Reis, LM; Elias, RM; Graciolli, FG; Jorgetti, V; Marques, IDB; Moysés, RMA; Pereira, RMR | 1 |
Antunes, HS; de Oliveira, TF; Farias, DS; Sampieri, MB; Santos, PS; Tinôco-Araújo, JE; Zen Filho, EV | 1 |
Baas, J; Barckman, J; Bechtold, JE; Søballe, K; Sørensen, M | 1 |
Bonanini, M; Fornaini, C; Giovannacci, I; Manfredi, M; Meleti, M; Merigo, E; Vescovi, P | 1 |
Gaitán-Cepeda, LA; Gómez-Clavel, JF; Vidal-Gutiérrez, X | 1 |
Brendel, C; Hamann, C; Hofbauer, LC; Krüger, A; Neubauer, A; Ramaswamy, A; Schnabel, M | 1 |
Al-Jamali, J; Joshi Oshero, J; Kovalova-Müller, A; Lemound, J; Metzger, MC; Sauerbier, S; Schmelzeisen, R; Veigel Merino, EA; Voss, PJ | 1 |
Brown, R; Cohen, A; Mancini, D; McMahon, DJ; Pandit, K; Restaino, S; Shane, E; Staron, RB; Stein, EM; Verna, EC; Young, P; Zhang, C | 1 |
Scott, DF; Smith, RR; Woltz, JN | 1 |
Delling, G; Grampp, S; Haas, M; Klaushofer, K; Kletzmayr, J; Leko-Mohr, Z; Mitterbauer, C; Oberbauer, R; Roschger, P; Schwarz, C; Steininger, R | 1 |
Berlakovich, G; Bodingbauer, M; Grampp, S; Klaushofer, K; Mühlbacher, F; Oberbauer, R; Pakrah, B; Peck-Radosavljevic, M; Rockenschaub, S; Roschger, P; Silberhumer, G; Steininger, R; Wekerle, T | 1 |
Bostan, F; Ozkaynak, C; Timurağaoğlu, A; Tuzuner, S; Undar, L | 1 |
1 review(s) available for zoledronic acid and Complication, Postoperative
Article | Year |
---|---|
Interventions for managing medication-related osteonecrosis of the jaw.
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Denosumab; Dental Care; Diphosphonates; Female; Humans; Hyperbaric Oxygenation; Imidazoles; Intercellular Signaling Peptides and Proteins; Jaw Diseases; Male; Oral Health; Osteonecrosis; Postoperative Complications; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Time Factors; Tooth Extraction; Zoledronic Acid | 2017 |
5 trial(s) available for zoledronic acid and Complication, Postoperative
Article | Year |
---|---|
A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.
Topics: Adult; Bone Density Conservation Agents; Bone Resorption; Female; Humans; Kidney Transplantation; Male; Postoperative Complications; Prospective Studies; Zoledronic Acid | 2019 |
Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.
Topics: Adult; Alendronate; Algorithms; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Double-Blind Method; Female; Heart Transplantation; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Placebos; Postoperative Care; Postoperative Complications; Zoledronic Acid | 2012 |
Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: preliminary results of a prospective randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Double-Blind Method; Female; Femur; Humans; Imidazoles; Male; Middle Aged; Postoperative Complications; Prospective Studies; Time Factors; Zoledronic Acid | 2013 |
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.
Topics: Biomarkers; Bone Density; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Diphosphonates; Female; Femur Neck; Humans; Imidazoles; Kidney Transplantation; Lumbar Vertebrae; Male; Middle Aged; Postoperative Complications; Zoledronic Acid | 2003 |
Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation.
Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Survival Analysis; Zoledronic Acid | 2007 |
9 other study(ies) available for zoledronic acid and Complication, Postoperative
Article | Year |
---|---|
Therapeutic effect of percutaneous kyphoplasty combined with anti-osteoporosis drug on postmenopausal women with osteoporotic vertebral compression fracture and analysis of postoperative bone cement leakage risk factors: a retrospective cohort study.
Topics: Bone Cements; Bone Density Conservation Agents; Cohort Studies; Combined Modality Therapy; Female; Fractures, Compression; Humans; Kyphoplasty; Middle Aged; Osteoporosis; Osteoporotic Fractures; Postmenopause; Postoperative Complications; Retrospective Studies; Risk Assessment; Risk Factors; Spinal Fractures; Zoledronic Acid | 2019 |
Skeletal dissemination in Paget's disease of the spine.
Topics: Alkaline Phosphatase; Diphosphonates; Disease Progression; Humans; Iatrogenic Disease; Male; Middle Aged; Osteitis Deformans; Postoperative Complications; Spine; Tomography, X-Ray Computed; Zoledronic Acid | 2018 |
Clinical and image findings in bisphosphonate-related osteonecrosis of the jaws.
Topics: Adult; Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Postoperative Complications; Radiography, Panoramic; Tomography, X-Ray Computed; Tooth Extraction; Zoledronic Acid | 2013 |
Preclinical evaluation of zoledronate to maintain bone allograft and improve implant fixation in revision joint replacement.
Topics: Animals; Arthroplasty, Replacement, Knee; Biomechanical Phenomena; Bone Density Conservation Agents; Bone Resorption; Bone Transplantation; Diphosphonates; Dogs; Female; Imidazoles; Knee Prosthesis; Postoperative Complications; Random Allocation; Reoperation; Transplantation, Homologous; Treatment Outcome; Zoledronic Acid | 2013 |
Autofluorescence as indicator for detecting the surgical margins of medication-related osteonecrosis of the jaws.
Topics: Aged; Aged, 80 and over; Bicuspid; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Neoplasms; Breast Neoplasms; Cementoplasty; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Laser Therapy; Lasers, Solid-State; Lung Neoplasms; Male; Margins of Excision; Middle Aged; Multiple Myeloma; Optical Imaging; Postoperative Complications; Tooth Extraction; Zoledronic Acid | 2016 |
Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Imidazoles; Male; Postoperative Complications; Random Allocation; Rats; Rats, Wistar; Tooth Extraction; Zoledronic Acid | 2017 |
Multimodal therapy for vertebral involvement of systemic mastocytosis.
Topics: Adult; Back Pain; Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Diphosphonates; Glucocorticoids; Histamine; Humans; Hypotension; Imidazoles; Male; Mast Cells; Mastocytosis, Systemic; Osteoporosis; Postoperative Complications; Prednisolone; Pressure; Proto-Oncogene Proteins c-kit; Spinal Fractures; Spine; Treatment Outcome; Vertebroplasty; Zoledronic Acid | 2009 |
Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
Topics: Aged; Aged, 80 and over; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Debridement; Dental Care; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Middle Aged; Oral Fistula; Osteotomy; Postoperative Complications; Retrospective Studies; Surgical Flaps; Surgical Wound Dehiscence; Suture Techniques; Treatment Outcome; Zoledronic Acid | 2012 |
Improvement of zoledronic-acid-induced jaw osteonecrosis with bortezomib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Doxorubicin; Female; Humans; Imidazoles; Mandibular Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Protease Inhibitors; Pyrazines; Tooth Extraction; Transplantation, Autologous; Vincristine; Zoledronic Acid | 2007 |